ABBOTT LABORATORIES Proceeds from Debt 2007-2026 | ABT
Beta
What is ABBOTT LABORATORIES's current proceeds from debt?
ABBOTT LABORATORIES (ABT) annual proceeds from debt for 2021 was $4.0M, a 99.69% decline from 2020. ABBOTT LABORATORIES proceeds from debt for the quarter ending March 31, 2026 was $19.86B.
What was ABBOTT LABORATORIES's proceeds from debt in 2020?
ABBOTT LABORATORIES annual proceeds from debt for 2020 was $1.28B, a 30.46% decline from 2019.
What was ABBOTT LABORATORIES's proceeds from debt in 2019?
ABBOTT LABORATORIES annual proceeds from debt for 2019 was $1.84B, a 54.05% decline from 2018.
What is ABBOTT LABORATORIES's 5-year proceeds from debt CAGR?
ABBOTT LABORATORIES proceeds from debt grew at a compound annual growth rate (CAGR) of 80.70% from FY2016 to FY2021, going from $14.93B to $4.0M over 5 years.
Proceeds from Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR-80.7%
FY2016
$14.93B
→
FY2021
$4.0M
07091011121315161718192021
5 years selected
Proceeds from Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2021 | $4.0M | -99.7% | 10-K |
| FY2020 | $1.28B | -30.5% | 10-K |
| FY2019 | $1.84B | -54.1% | 10-K |
| FY2018 | $4.01B | -40.5% | 10-K |
| FY2017 | $6.74B | -54.9% | 10-K |
| FY2016 | $14.93B | +501.0% | 10-K |
| FY2015 | $2.48B | +27511.1% | 10-K |
| FY2013 | $9.0M | -99.9% | 10-K |
| FY2012 | $14.70B | +1370.0% | 10-K |
| FY2011 | $1.00B | -75.0% | 10-K |
| FY2010 | $4.00B | +33.3% | 10-K |
| FY2009 | $3.00B | -14.3% | 10-K |
| FY2007 | $3.50B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →